Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction

Abstract

Experimental data indicate that stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) might have potential as a novel therapeutic strategy for acute myocardial infarction. The prospective beneficial effects of G-CSF can be attributed mainly to a direct action on injured myocardium rather than on differentiation of mobilized bone marrow stem cells into cardiac myocytes. This article reviews the evidence for the potential cardioprotective effects of G-CSF and discusses future investigations regarding pharmacologic stem cell activation and mobilization with G-CSF in the setting of acute myocardial infarction.

Key Points

  • Experimental data indicate that stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) has potential as a novel regenerative strategy after acute myocardial infarction

  • The prospective beneficial effects of G-CSF can be attributed mainly to a direct action on injured myocardium rather than on differentiation of mobilized bone marrow stem cells into cardiac myocytes

  • Antiapoptotic and angiogenic effects of G-CSF could conceivably have an impact on left ventricular remodeling after acute myocardial infarction

  • With regards to future treatment strategies for acute myocardial infarction, further experimental and clinical studies are needed to identify effective and safe ways to use G-CSF

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jessup M and Brozena S (2003) Heart failure. N Engl J Med 348: 2007–2018

    Article  Google Scholar 

  2. Nian M et al. (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543–1553

    Article  CAS  Google Scholar 

  3. Papayannopoulou T (2004) Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103: 1580–1585

    Article  CAS  Google Scholar 

  4. Orlic D et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–705

    Article  CAS  Google Scholar 

  5. Orlic D et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344–10349

    Article  CAS  Google Scholar 

  6. Ohtsuka M et al. (2004) Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 18: 851–853

    Article  CAS  Google Scholar 

  7. Minatoguchi S et al. (2004) Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109: 2572–2580

    Article  CAS  Google Scholar 

  8. Kawada H et al. (2004) Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581–3587

    Article  CAS  Google Scholar 

  9. Iwanaga K et al. (2004) Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 325: 1353–1359

    Article  CAS  Google Scholar 

  10. Harada M et al. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11: 305–311

    Article  CAS  Google Scholar 

  11. Sugano Y et al. (2005) Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 65: 446–456

    Article  CAS  Google Scholar 

  12. Deindl E et al. (2006) G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 20: 956–958

    Article  CAS  Google Scholar 

  13. Ueda K et al. (2006) Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 26: e108−e113

    Article  CAS  Google Scholar 

  14. Norol F et al. (2006) Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 102: 4361–4368

    Article  Google Scholar 

  15. Deten A et al. (2005) Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 65: 52–63

    Article  CAS  Google Scholar 

  16. Dawn B et al. (2006) Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 98: 1098–1105

    Article  CAS  Google Scholar 

  17. Hope SA and Meredith IT (2003) Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern Med J 33: 380–386

    Article  CAS  Google Scholar 

  18. Kronenwett R et al. (2000) The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells. Stem Cells 18: 320–330

    Article  CAS  Google Scholar 

  19. Weber C (2003) Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J Mol Med 81: 4–19

    Article  CAS  Google Scholar 

  20. Iwasaki H et al. (2006) Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113: 1311–1325

    Article  CAS  Google Scholar 

  21. Broxmeyer HE et al. (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Mol Med 201: 1307–1318

    CAS  Google Scholar 

  22. Orschell-Traycoff CM et al. (2000) Homing and engraftment potential of Sca-1(+)lin(–) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 96: 1380–1387

    CAS  PubMed  Google Scholar 

  23. Liles WC et al. (2003) Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102: 2728–2730

    Article  CAS  Google Scholar 

  24. Liles WC et al. (2004) Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with G-CSF by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 45: 295–300

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hüseyin Ince.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ince, H., Nienaber, C. Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction. Nat Rev Cardiol 4 (Suppl 1), S119–S122 (2007). https://doi.org/10.1038/ncpcardio0732

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0732

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing